A Study Evaluating Treatment Regimens Containing Vebicorvir (ABI-H0731) in Participants With Chronic Hepatitis B Infection
Study sponsor: Assembly Biosciences
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2023-03-30Actual
Enrollment · participants65Actual
Source updated2023-11-14Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.